New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 21, 2012
10:20 EDTGSK, AET, VVUS, PFE, OREX, RHHBY, ARNAVIVUS rallies after Aetna revises obesity drug policy
In a Clinical Policy Bulletin revision dated November 20, 2012, Aetna (AET) specified criteria under which the insurer considers weight reduction medications as "medically necessary" for treatment of obesity. Aetna stated, "For members whose medical policies do not exclude weight reduction medications or services and supplies for or related to weight reduction programs, Aetna covers [the following] drugs under the medical benefit, not the pharmacy benefit." Among the medications that have been approved by the FDA for weight reduction which would be covered under its policy, Aetna listed Qsymia, marketed by VIVUS (VVUS), Belviq from Arena Pharmaceuticals (ARNA), Didrex from Pfizer's (PFE) Pharmacia unit, Roche's (RHHBY) Xenical, and GlaxoSmithKline's (GSK) Alli. Early session strength in shares of VIVUS and Arena has been attributed to Aetna's policy revision, and shares of Orexigen Therapeutics (OREX), which is developing a weight loss treatment that is being considered by the FDA for approval, have also moved higher. In early morning trading, VIVUS advanced $1.58, or 15.27%, to $11.93, Arena gained 20c, or 2.24%, to $9.13 and Orexigen added 30c, or 6.88%, to $4.66.
News For VVUS;ARNA;OREX;AET;RHHBY;PFE;GSK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
June 22, 2015
06:37 EDTAETHealth insurers may change policies based on King v. Burwell ruling, NYT says
Subscribe for More Information
June 21, 2015
16:03 EDTAETAetna makes offer to acquire Humana, WSJ says
Subscribe for More Information
June 19, 2015
16:24 EDTAETStocks end week higher after Fed reassures on gradual pace of rate increases
Subscribe for More Information
14:07 EDTAETOptions with increasing implied volatility: NFLX CI TRIP AET
10:09 EDTAETFly Watch: Supreme Court may release key ACA decision soon
Subscribe for More Information
09:18 EDTAETHumana most likely target in Managed Care, says FBR Capital
FBR Capital says Humana (HUM) is the most likely acquisition target in the Managed Care space, with Aetna (AET), Anthem (ANTM) and Cigna (CI) as the likely acquirers. The firm believes Anthem would benefit the most from the acquisition of Humana. It also thinks UnitedHealth (UNH) could look to acquire Aetna or Cigna. FBR thinks one or two more large deals in the space are possible.
07:37 EDTAETSupreme Court decision on ACA suit due soon, says UBS
Subscribe for More Information
June 18, 2015
13:08 EDTGSKGlaxoSmithKline management to meet with Piper Jaffray
Meeting to be held in Minneapolis on June 23 hosted by Piper Jaffray.
11:31 EDTAETOptions with increasing implied volatility
Subscribe for More Information
09:35 EDTPFEActive equity options trading on open
Subscribe for More Information
07:51 EDTAETIncrease in 3R backstop most positive for Humana, says Leerink
Subscribe for More Information
07:38 EDTAETLeerink to hold a roundtable
Subscribe for More Information
June 17, 2015
11:08 EDTAETOptions with increasing implied volatility
Subscribe for More Information
10:00 EDTPFEOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AbbVie (ABBV) initiated with an Overweight at Piper Jaffray... Arista Networks (ANET) initiated with a Buy at Sterne Agee CRT... Astec (ASTE) initiated with a Buy at Maxim... Bristol-Myers (BMY) initiated with an Underweight at Piper Jaffray... Community Healthcare (CHCT) initiated with an Outperform at Oppenheimer... Eli Lilly (LLY) initiated with an Overweight at Piper Jaffray... Fitbit (FIT) initiated with a Buy ahead of IPO at Dougherty... Hortonworks (HDP) initiated with a Buy at Mizuho... II-VI (IIVI) initiated with a Buy at Benchmark Co.... J Sainsbury (JSAIY) initiated with an Underperform at Credit Suisse... McDermott (MDR) initiated with an Outperform at Cowen... Merck (MRK) initiated with a Neutral at Piper Jaffray... Molina Healthcare (MOH) initiated with a Buy at UBS... Pacific DataVision (PDVW) initiated with a Buy at Canaccord... Pfizer (PFE) initiated with an Overweight at Piper Jaffray... Quest Resource (QRHC) initiated with a Buy at Roth Capital... Regional Management (RM) initiated with a Buy at Janney Capital... Rofin-Sinar (RSTI) initiated with a Buy at Benchmark Co.... Salesforce (CRM) initiated with a Neutral at Exane BNP Paribas... Sprouts Farmers Markets (SFM) initiated with a Neutral at Cleveland Research... Tesco (TSCDY) initiated with an Underperform at Credit Suisse... WM Morrison (MRWSY) initiated with a Neutral at Credit Suisse... WWE (WWE) initiated with a Buy at BTIG... World Acceptance (WRLD) initiated with a Buy at Janney Capital... Zafgen (ZFGN) initiated with a Buy at SunTrust.
08:45 EDTOREXOrexigen management to meet with Leerink
Subscribe for More Information
07:48 EDTAETHealth insurers seen consolidating from five to three in 'megadeals,' WSJ says
Subscribe for More Information
07:42 EDTAETAetna price target raised to $145 from $135 at Leerink
Subscribe for More Information
07:25 EDTPFEPiper calls Bristol 'modestly overvalued,' starts shares with sell
Subscribe for More Information
07:14 EDTRHHBYProthena announces PRX002 was safe, well tolerated
Subscribe for More Information
05:31 EDTPFEPfizer initiated with an Overweight at Piper Jaffray
Target $45.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use